VFA
BNTX icon

Valeo Financial Advisors’s BioNTech BNTX Stock Holding History

Valeo Financial Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-644
Closed -$70K – 688
2021
Q1 		$70K Buy
644
+15
+2% +$1.59K ﹤0.01% 737
2020
Q4 		$51K Buy
+629
New +$61.7K ﹤0.01% 773

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Valeo Financial Advisors's BNTX Position: Q2 2021 in Review

Valeo Financial Advisors sold out of BioNTech (BNTX) in Q2 2021, closing a stake of 644 shares — an estimated $70K sold.

Valeo Financial Advisors first reported a position in BNTX in Q4 2020 and held it in 2 quarters. The position peaked at $70K in Q1 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2021.

  • Valeo Financial Advisors reported no remaining BioNTech position as of Q2 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 644 BioNTech shares in Q2 2021, an estimated $70K.
  • Valeo Financial Advisors first reported a position in BioNTech in Q4 2020 and held it in 2 quarters.
  • Valeo Financial Advisors's BioNTech position peaked at $70K in Q1 2021.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.